1,103 reports of this reaction
1.5% of all NICOTINE reports
#13 most reported adverse reaction
APPLICATION SITE IRRITATION is the #13 most commonly reported adverse reaction for NICOTINE, manufactured by Haleon US Holdings LLC. There are 1,103 FDA adverse event reports linking NICOTINE to APPLICATION SITE IRRITATION. This represents approximately 1.5% of all 74,737 adverse event reports for this drug.
NICOTINE has an overall safety score of 78 out of 100. Patients taking NICOTINE who experience application site irritation should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
APPLICATION SITE IRRITATION is a less commonly reported adverse event for NICOTINE, but still significant enough to appear in the safety profile.
In addition to application site irritation, the following adverse reactions have been reported for NICOTINE:
The following drugs have also been linked to application site irritation in FDA adverse event reports:
APPLICATION SITE IRRITATION has been reported as an adverse event in 1,103 FDA reports for NICOTINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
APPLICATION SITE IRRITATION accounts for approximately 1.5% of all adverse event reports for NICOTINE, making it a notable side effect.
If you experience application site irritation while taking NICOTINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.